(Q34334018)

1 August 2017

1 reference

title

Bovine mastitis and intramammary drug delivery: review and perspectives (English)

1 reference

1 August 2017

1 reference

Gruet P

1

1 reference

1 August 2017

Maincent P

series ordinal

2

1 reference

1 August 2017

Berthelot X

series ordinal

3

1 reference

1 August 2017

Kaltsatos V

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

50

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

245-259

1 reference

Economics of mastitis and mastitis control.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Partial budget of the discounted annual benefit of mastitis control strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Economics of mastitis control

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Influence of Involuntary Culling on Optimum Culling Rates and Annualized Net Revenue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Modeling the impact of mastitis on milk production by dairy cows

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

A summary of the reasons why farmers cull cows.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effect of dexamethasone on experimental Escherichia coli mastitis in the cow

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effect of steroidal anti-inflammatory drugs on Escherichia coli endotoxin-induced mastitis in the cow.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Immunization and immunotherapy for mastitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effects of recombinant granulocyte colony-stimulating factor on Staphylococcus aureus mastitis in lactating dairy cows

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Staphylococcus aureus Mastitis: Pathogenesis and Treatment with Bovine Interleukin-1β and Interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Antibacterial Activity of Bovine Mammary Gland Lymphocytes Following Treatment with Interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Pathological Changes in Bovine Mammary Glands Following Intramammary Infusion of Recombinant Interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Recombinant bovine interleukin-2 and dry cow therapy: efficacy to cure and prevent intramammary infections, safety, and effect on gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Advances in the therapy for mastitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Growth inhibition of mastitis pathogens by long-chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

1 reference

7 January 2021

Environmental pathogens and intramammary infection during the dry period

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Environmental mastitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

The prophylactic effect of a teat sealer on bovine mastitis during the dry period and the following lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Efficacy of a Fatty Acid-Lactic Acid Postmilking Teat Germicide in Reducing Incidence of Bovine Mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Evaluation of postmilking teat germicides containing Lauricidin, saturated fatty acids, and lactic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Evaluation of two iodophor teat germicides: activity against Staphylococcus aureus and Streptococcus agalactiae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Germicidal activity of a chlorous acid-chlorine dioxide teat dip and a sodium chlorite teat dip during experimental challenge with Staphylococcus aureus and Streptococcus agalactiae

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effects of premilking and postmilking teat disinfectants on teat skin condition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Field trials with cefoperazone in the treatment of bovine clinical mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Management of dry cows to reduce mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

A note on dry cow therapy in the control of bovine mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Elements of mastitis control

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Dry cow therapy as a means of controlling bovine mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Evaluation of a long-acting intramammary preparation containing high doses of penicillin and streptomycin for use in dry cows

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Comparative efficacy of dry-cow treatment regimens against Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Mastitis—Progress on Control

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

The prophylactic effect of a dry-cow antibiotic against Streptococcus uberis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effects of dry cow intramammary therapy on quarter infections in the dry period

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effects of antibiotic therapy at drying off on mastitis in the dry period and early lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Strategies for mastitis control: dry cow therapy and culling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Association Between Dry Cow Theraphy, Clinical Mastitis, and Somatic Cell Count Score with Milk and Fat Production in Ten New Zealand Dairy Herds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Phagocytosis of Staphylococcus aureus by bovine mammary gland macrophages and intracellular protection from antibiotic action in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Microencapsulation of antimicrobial ceftiofur drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

Lysostaphin: Use of a Recombinant Bactericidal Enzyme as a Mastitis Therapeutic

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900160-0

7 January 2021

10.1016/S0169-409X(01)00160-0

Identifiers

DOI

1 reference

1 August 2017

1 reference